Optigen
AssetAlso Citicoline
Citicoline dietary supplement providing neuroprotection to retinal ganglion cells.
- Stage
- Human trials
- Modality
- Supplement
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Glaucoma
Human trials, Completed, NCT07861243, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors1
- Signals9
Every asset’s record: target, stage, trials and the evidence behind it.